Keyphrases
Warfarin
95%
Direct Oral Anticoagulants
67%
Patient-reported Outcomes
60%
Oral Anticoagulants
60%
Health-related Quality of Life
39%
Monitoring Service
30%
Adverse Event Reporting
30%
Service Model
30%
Old Drugs
30%
New Drugs
30%
Prescribing Trends
30%
Patient Satisfaction
24%
Royal Hospital
22%
Infirmary
18%
Huddersfield
18%
Royal
18%
Atrial Fibrillation
17%
Quality of Life Satisfaction
15%
Quality of Life Assessment
15%
Hospitalized Patients
11%
Blood Monitoring
9%
Dose Adjustment
9%
Venous Thromboembolism Prevention
9%
New Agents
9%
Anticoagulation Treatment
9%
Traditional Management
9%
Pharmacokinetics
9%
Patient Adherence
9%
Clinical Practitioners
9%
Pharmacodynamics
9%
Patient Health
9%
Prescribers
9%
Patient Perspective
9%
Serious Events
9%
Anticoagulants
9%
Fatal Accidents
9%
Venous Thromboembolism Treatment
7%
Low Burden
7%
Intense Monitoring
7%
Benefit Measure
7%
Oral Anticoagulant Therapy
7%
Knowledge Measure
7%
Cochrane Collaboration Tool
7%
Healthcare Treatment
7%
Service Delivery
7%
Anticoagulation
7%
Service Cost
7%
Healthcare
7%
High Quality of Life
7%
Patient Response
7%
Nursing and Health Professions
Warfarin
74%
Patient-Reported Outcome
60%
Anticoagulant Agent
60%
Quality of Life
39%
Systematic Review
30%
Adherence
27%
Patient Satisfaction
23%
Compliance
21%
Anticoagulation
19%
Atrial Fibrillation
15%
Venous Thromboembolism
15%
Pharmacodynamics
9%
Gold Standard
9%
Cerebrovascular Accident
9%
Health Care Delivery
6%
Anticoagulant Therapy
6%
Health Care
6%
Practice Guideline
6%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Anticoagulant Agent
75%
Direct Oral Anticoagulant
37%
Adverse Event
30%
Observational Study
30%
Venous Thromboembolism
22%
Atrial Fibrillation
22%
Cerebrovascular Accident
15%
Pharmacodynamics
15%
Pharmacokinetic
15%
